Application 761430

Type
BLA
Sponsor
JANSSEN BIOTECH

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761430Imaavynipocalimab-aahu351(a)Rx2026-06-01

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001IMAAVYNIPOCALIMAB-AAHUINJECTABLE;INJECTION300MG/1.62ML(185MG/ML)NoNo
002IMAAVYNIPOCALIMAB-AAHUINJECTABLE;INJECTION1200MG/6.5ML(185MG/ML)NoNo

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 ยท 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
IMAAVYNIPOCALIMAB-AAHUJanssen Biotech, Inc.8886274c-f2b2-48af-85c1-2f90bfe304b82025-05-07Warnings, Adverse reactionsExact identifier
application number: BLA761430

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
82433ORIG 2025-06-02
82140ORIG 2025-05-05
82076ORIG 2025-04-30